IP Library › Assignment 039573/0417
Patent Assignment
Reel/Frame 039573/0417

Change of Name

Recorded: 2016-08-04 Pages: 3
Assignor
N30 PHARMACEUTICALS, INC.
Executed: 2015-02-11
Assignee
NIVALIS THERAPEUTICS, INC.
3122 STERLING CIRCLE, BOULDER, COLORADO, 80301
Covered Property (1)
Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors
Patent: 9,856,219 →
Application: 15/228,088 →
Publication: US 2016/0340312
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 4, 2016
From: SUN, XICHENG; QIU, JIAN; STOUT, ADAM
To: N30 PHARMACEUTICALS, LLC,
Reel/Frame 039573/0397 →
Change of Name Aug 4, 2016
From: N30 PHARMACEUTICALS, LLC
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 039573/0408 →
Assignment of Assignor's Interest Jul 13, 2018
From: ALPINE IMMUNE SCIENCES, INC.
To: LAUREL VENTURE CAPITAL LTD.
Reel/Frame 046341/0795 →
Assignment of Assignor's Interest Apr 4, 2019
From: LAUREL VENTURE CAPITAL LTD.
To: LAUREL THERAPEUTICS LTD.
Reel/Frame 048787/0883 →